UBC PiMS Research Group
Pharmacoepidemiology in Multiple Sclerosis Research Group

Slideshow

PEOPLE IN PROFILE – JOSÉ WIJNANDS

Meet José–cycling enthusiast hoping to improve the prognosis of people living with Multiple Sclerosis.

New article published in The Lancet Neurology

PiMS member José M A Wijnands article, “Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study” was recently published in Lancet Neurology.

What’s new for ‘microbiota multiple sclerosis’ in PubMed

Helen Tremlett’s new article, “The gut microbiome in human neurological disease: A review”, was recently published in Annals of Neurology.

Association between anti-depressants drugs on the progression of multiple sclerosis.

Researchers found no evidence to suggest that exposure to the antidepressants ‘selective serotonin reuptake inhibitors’ were associated with a delay in MS disability accumulation or progression.

Unique Relationship Found Between Gut Microbiota and Immune Markers in Kids with MS

Children with multiple sclerosis (MS) may show a disruption in the balance of bacteria in the gut as early as two years into the disease course, suggests new findings from Dr. Helen Tremlett.

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls

Dr. Helen Tremlett’s latest article has been published in BMC Neurology.

PiMS Group Featured in MS Discovery Podcasts

The PiMS research group was recently featured by the MS Discovery Forum. Drs. Kowalec, Razaz and Kingwell spoke about their respective research topics, which were presented at the ECTRIMS 2015 annual congress in Barcelona. Please visit the following links for the podcasts: Dr. Neda Razaz on children of parents with MS: http://www.msdiscovery.org/news/podcasts/27617-episode-67-neda-razaz-children-parents-ms Dr. Elaine Kingwell on MS trends […]

DIFFERENCES BETWEEN MS CLINIC AND NON-CLINIC USERS INDICATE KNOWLEDGE GAPS AND MORE, STUDY FINDS

via cbh: If most of what we know about multiple sclerosis (MS) patients comes from patients who access MS- clinics, how much do we really know about MS patients? New research from Kyla McKay and Dr. Elaine Kingwell, part of the Pharmacoepidemiology in Multiple Sclerosis (PiMS) research team led by Dr. Helen Tremlett, evaluated population-level […]

Helen Tremlett participates in latest issue of NARCOMS Now

Please read more at www.narcoms.org/narcomsnow.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia